IntroductionThis year, the Regulation on the Administration of Clinical Research and Clinical Translation of New Biomedical Technologies (State Council Decree No. 818; hereinafter referred to as the “Regulation”) officially came into effect. For new technologies involving human cells and molecules, ...

IntroductionBacterial vaginosis (BV) is a clinical condition characterized by the replacement of normal hydrogen peroxide-producing Lactobacillus species in the vagina by a high concentration of characteristic aerobic and anaerobic bacterial communities, without apparent inflammation of the vaginal ...

IntroductionClinical trials are an essential pathway for bringing innovative therapies to patients. However, they are often characterized by long development cycles, complex operational processes, significant risks, and substantial investment requirements. Any unexpected challenge may potentially im...

Recent advances in generative AI have accelerated its adoption across industries, prompting organizations to explore new ways to enhance productivity and operational efficiency. At the same time, an equally important question has emerged: in the highly regulated and risk-sensitive biopharmaceutical ...

Introduction:In clinical drug development, sponsors may encounter regulatory requests for additional randomized dose-finding studies that disrupt established development plans. In other cases, the justification for a proposed Optimal Dose may fail to meet regulatory expectations, leading to delays i...

The “Radiopharma at Reflection Point: Bridging the Chain, Forging a high-quality Future” Innovation Salon, co-hosted by Asymchem and Healthcare Executive, was concluded successfully.The event brought together representatives from leading multinational pharmaceutical companies, including AstraZeneca ...

The BIO International Convention 2026, widely recognized as the largest and most influential event in the global biotechnology industry, will be held from June 22 to 25, 2026, in San Diego, California, USA.The convention is expected to attract more than 20,000 industry leaders, researchers, business...

Polypharmacy and Safe Navigation in Older AdultsINTRODUCTIONIt is widely recognized that more than 70% of people aged 65 and above in China suffer from one or more chronic diseases, making polypharmacy extremely common. While taking medications as prescribed is the foundation of disease control, the...

Effective Management of Unblinded Operations in Clinical TrialsAsymchem Clinical Monitoring DepartmentAbstract: Unblinded operations represent a critical component of clinical research. Because they directly involve investigational product management and treatment allocation information, proper plan...

Considerations for Writing and Submitting Development Safety Update Reports (DSURs) for Multi-Regional Clinical Trials (MRCTs) Abstract: This article explores key considerations in writing and submitting Development Safety Update Reports (DSURs) for Multi-Regional Clinical Trials (MRCTs).Introductio...

Output Formats and Applications of the SAS Report Generation ToolSAS and Proc Report in Clinical Data ScienceSAS (Statistical Analysis System) is a widely used professional analytics software for data analysis, statistical modeling, and data mining, with extensive applications in clinical data scien...

Asymchem Clinical (Clin-nov) and Shandong Provincial Qianfoshan Hospital Form Catalytic Strategic PartnershipAsymchem Clinical (Clin-Nov) Asymchem Clinical (Clin-nov) and Shandong Provincial Qianfoshan Hospital Form Strategic Partnership to Advance Clinical Research Jinan, China – August 28, 2024 –A...

Asymchem Clinical (Clin-nov), a global, full service CRO with presence in China, US, Malaysia Singapore and Australia, proudly announces the successful completion of its recent audit by the Association of International Contract Research Organizations (AICROS). To mark this significant achievement, A...

Asymchem Clinical, a prominent full service Contract Research Organization (CRO) with a growing global footprint, recently announced its induction into the Association of International Contract Research Organizations (AICROS), a consortium of CROs around the world offering clinical research services...

On July 12, 2024, the academic salon titled s lifecycle, serving clients across the United States, Europe, Japan, and other regions. Their innovative solutions provide critical support for decision-making in clinical research, ensuring efficient and successful outcomes for global partners.

Asymchem Clinical (Clin-nov) recently invited Mr. Sun Haiquan, Senior Director of the Statistical Programming Department, to present at the Chengdu-Chongqing Biostatistics Forum (CBF). His keynote address, titled s commitment to advancing Biostatistics and supporting development and implementation o...

On Saturday December the 10th, Clin-nov North America held a year-end celebration event in Toronto attended by decision-makers from the medical, pharmaceutical and biotech industries. Executives from finance, marketing and academia were also in attendance to support us! It was a joyous event to conc...

September 22-23 – The .

September 17-19 - .

September 2 - The live streaming was jointly organized by Drug Hunters Club, Association of Experts in Chengdu High-Tech Bio-Industry, together with Asymchem, Asymchem Clinical (Clin-nov), Yougen Medtech, Tianjin Technology Innovation Center for Clinical Research (TICCR), and Chengdu Jingrunze Gene ...

August 26th-27th – Asymchem Clinical (Clin-nov) was invited by the Cell Therapy Branch of Guangdong Medical Association to attend Key Considerations in the IND Application for Stem Cell Products”. Nearly 300+ attendees participated on site.

July 27 – Clin-nov Medical was invited by the Guangdong Pharmaceutical Association to participate in the training course on Introduction of iDMC (independent Data Monitoring Committee)”. The training session was conducted via a live stream, with nearly 200 attendees online. This training aimed to di...